Form EFFECT Biodexa Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 30, 2026 |
| Accession Number: | 0001214659-26-003933 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ECLAT Health Solutions to Showcase evaire Surface for ACO Total Cost of Care Management at NAACOS Fall 2026 Conference
- NEXT PROPERTIES ANNOUNCES AMENDMENT TO EXCHANGE OFFERS FOR ANY & ALL OF 7.700% SENIOR SUSTAINABILITY-LINKED NOTES DUE 2032, 7.375% SENIOR GREEN NOTES DUE 2034, 6.950% SENIOR NOTES DUE 2044 AND 6.3
- Discovery Senior Living to Participate in 2026 NIC Fall Conference
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
